Variation in a Repeat Sequence Determines Whether a Common Variant of the Cystic Fibrosis Transmembrane Conductance Regulator Gene Is Pathogenic or Benign
- 31 January 2004
- journal article
- research article
- Published by Elsevier in American Journal of Human Genetics
- Vol. 74 (1), 176-179
- https://doi.org/10.1086/381001
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A variable dinucleotide repeat in the CFTR gene contributes to phenotype diversity by forming RNA secondary structures that alter splicingProceedings of the National Academy of Sciences, 2004
- Cystic fibrosis screening using the College panel: Platform comparison and lessons learned from the first 20,000 samplesGenetics in Medicine, 2002
- Lung Disease Associated with the IVS8 5T Allele of the CFTR GeneAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Functional Analysis of cis-Acting Elements Regulating the Alternative Splicing of Human CFTR Exon 9Human Molecular Genetics, 1999
- Linkage disequilibrium between the M470V variant and the IVS8 polyT alleles of the CFTR gene in CBAVD.Journal of Medical Genetics, 1998
- The diagnosis of cystic fibrosis: A consensus statementThe Journal of Pediatrics, 1998
- Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation.JCI Insight, 1998
- CFTR gene variant for patients with congenital absence of vas deferens.1995
- Mutations in the Cystic Fibrosis Gene in Patients with Congenital Absence of the Vas DeferensNew England Journal of Medicine, 1995
- Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNANature Genetics, 1993